Bentley P J
J Physiol. 1968 Mar;195(2):317-30. doi: 10.1113/jphysiol.1968.sp008460.
1 Amiloride inhibits Na transport and short-circuit current (SCC) across the toad bladder. It is 1000 times more active at the mucosal than serosal surface. The lowest effective concentration was 10(-7)M.2. The inhibition was non-competitive with the sodium on the mucosal side of the bladder.3. Vasopressin, cyclic adenosine monophosphate (AMP) and aldosterone increased Na transport and SCC across the bladder and these effects were inhibited by amiloride.4. The antagonism of amiloride for vasopressin was non-competitive.5. Amphotericin B also increases Na transport across the bladder but its action was not changed by amiloride.6. Amiloride was without effects on SCC and diffusion potentials in bladders metabolically inhibited with CN(-) and iodoacetic acid (IAA).7. Neither plasma albumin, Ca(2+) nor adenosine triphosphate (ATP) altered the effects of amiloride.8. The only structural analogue of amiloride found to reduce SCC similarly was guanidine which was 1000 times less active. Pyrazine and a substituted pyrazine analogue were without effect. Neither guanidine nor the substituted pyrazine compound were competitive with amiloride.9. Amiloride had no effect on the osmotic permeability of the toad bladder either in the presence or absence of vasopressin.10. Na transport across the toad colon was also reduced by 10(-5)M amiloride at the mucosal surface.11. The possible mechanism of action of amiloride is discussed.
氨氯吡咪抑制蟾蜍膀胱的钠转运和短路电流(SCC)。它在黏膜侧的活性比浆膜侧高1000倍。最低有效浓度为10⁻⁷M。
这种抑制在膀胱黏膜侧对钠是非竞争性的。
血管加压素、环磷酸腺苷(AMP)和醛固酮增加蟾蜍膀胱的钠转运和SCC,而这些作用被氨氯吡咪抑制。
氨氯吡咪对血管加压素的拮抗作用是非竞争性的。
两性霉素B也增加蟾蜍膀胱的钠转运,但其作用不受氨氯吡咪影响。
氨氯吡咪对用氰化物(CN⁻)和碘乙酸(IAA)代谢抑制的膀胱的SCC和扩散电位无影响。
血浆白蛋白、钙离子(Ca²⁺)和三磷酸腺苷(ATP)均未改变氨氯吡咪的作用。
发现的唯一能类似地降低SCC的氨氯吡咪结构类似物是胍,其活性比氨氯吡咪低1000倍。吡嗪和一种取代吡嗪类似物无作用。胍和取代吡嗪化合物与氨氯吡咪均无竞争性。
无论有无血管加压素,氨氯吡咪对蟾蜍膀胱的渗透通透性均无影响。
黏膜表面10⁻⁵M的氨氯吡咪也降低蟾蜍结肠的钠转运。
讨论了氨氯吡咪可能的作用机制。